What we found on the web about Nicvax
NicVAX is a nicotine conjugate vaccine intended to reduce or eliminate physical addiction to nicotine. According to the National Institute on Drug Abuse, NicVAX can potentially be ...
People Developers of vaccines. Thomas Francis, Jr., MD; Maurice Hilleman; Edward Jenner, MD; Paul Offit, MD; Louis Pasteur, PhD; Albert Sabin, MD; Jonas Salk, MD
Sponsors and Collaborators: National Institute on Drug Abuse (NIDA) Nabi Biopharmaceuticals: Information provided by: National Institute on Drug Abuse (NIDA)
Sponsors and Collaborators: Nabi Biopharmaceuticals National Institute on Drug Abuse (NIDA) Information provided by: National Institute on Drug Abuse (NIDA)
ROCKVILLE, Md., Jan. 25 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals (Nasdaq: NABI) today provided an update on the strategic direction of NicVAX(TM) (Nicotine Conjugate ...
Data Presented Today at the American Heart Association Scientific Sessions 2007 in Orlando, Florida Nabi Biopharmaceuticals today announced the successful compl
Although NicVAX does last a long time, the effects are not lifelong, so the treatment should be reversible in time. Preliminary studies have shown that a treatment of NicVAX lasts ...
Even if NicVAX was shown to be effective in preventing and treating nicotine addiction, access to it might be limited. Experimental drugs such as NicVAX might not be covered ...
-- Grant Enables Nabi Biopharmaceuticals to Advance NicVAX To Phase III Pivotal Trials -- BOCA RATON, Fla., Sept. 12 /PRNewswire-FirstCall/ -- Nabi ...
Nabi Biopharmaceuticals (Nasdaq:NABI) announced today positive final results from its Phase 2 NicVAX(r) (Nicotine Conjugate Vaccine) schedule optimization immunogenicity study to ...
Here is what users have to say about Nicvax

NicVAX is a nicotine conjugate vaccine intended to reduce or eliminate physical addiction to nicotine. According to the National Institute on Drug Abuse, NicVAX can potentially be used to inoculate against addiction. This proprietary vaccine is being developed by Nabi Biopharmaceuticals with the aid of the University of Houston–Clear Lake and University of Minnesota. NicVAX consists of the hapten 3'-aminomethylnicotine which has been conjugated (attached) to Pseudomonas aeruginosa exoprotein A.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!